CIRCHEM AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.6 SEK | +0.39% |
|
-7.14% | +0.78% |
| 02-14 | CirChem AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
| 2023 | CirChem AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Capitalization 1 | 102.3 | 184.2 | 103 | 74.51 |
| Enterprise Value (EV) 1 | 87.06 | 174.4 | 94.95 | 66.85 |
| P/E ratio | -8.47 x | -10.1 x | -4.22 x | -4.35 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | 47 x | 66.4 x | 25.7 x | 10.8 x |
| EV / Revenue | 40 x | 62.8 x | 23.7 x | 9.7 x |
| EV / EBITDA | -9.84 x | -10.4 x | -4.78 x | -4.29 x |
| EV / FCF | 22,449,545 x | 127,705,297 x | -6,443,597 x | -3,170,812 x |
| FCF Yield | 0% | 0% | -0% | -0% |
| Price to Book | 2.3 x | 6.98 x | 4.1 x | 2.12 x |
| Nbr of stocks (in thousands) | 12,790 | 12,790 | 17,191 | 28,881 |
| Reference price 2 | 8.000 | 14.40 | 5.990 | 2.580 |
| Announcement Date | 21-04-19 | 22-05-02 | 23-04-27 | 24-04-30 |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.1677 | 0.0188 | 2.178 | 2.775 | 4.012 | 6.896 |
| EBITDA 1 | -0.7913 | -1.789 | -8.852 | -16.73 | -19.86 | -15.58 |
| EBIT 1 | -0.8741 | -1.872 | -8.935 | -16.81 | -19.94 | -15.62 |
| Operating Margin | -521.12% | -9,974.7% | -410.25% | -605.82% | -496.99% | -226.55% |
| Earnings before Tax (EBT) 1 | -1.214 | -3.262 | -9.486 | -18.15 | -22.72 | -17.14 |
| Net income 1 | -1.214 | -3.262 | -9.486 | -18.15 | -22.72 | -17.14 |
| Net margin | -723.78% | -17,379.8% | -435.55% | -654.07% | -566.29% | -248.56% |
| EPS | - | - | -0.9443 | -1.419 | -1.420 | -0.5935 |
| Free Cash Flow | - | -25.59 | 3.878 | 1.365 | -14.74 | -21.14 |
| FCF margin | - | -136,339.64% | 178.07% | 49.2% | -367.31% | -306.53% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 20-04-06 | 20-04-06 | 21-04-19 | 22-05-02 | 23-04-27 | 24-04-30 |
1SEK in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 6.97 | 6.54 | - | - | - | - |
| Net Cash position 1 | - | - | 15.3 | 9.81 | 8.02 | 7.66 |
| Leverage (Debt/EBITDA) | -8.81 x | -3.654 x | - | - | - | - |
| Free Cash Flow | - | -25.6 | 3.88 | 1.37 | -14.7 | -21.1 |
| ROE (net income / shareholders' equity) | - | -16% | -24.6% | -51.2% | -88.2% | -56.9% |
| ROA (Net income/ Total Assets) | - | -3.53% | -11% | -19.3% | -24.3% | -17.8% |
| Assets 1 | - | 92.46 | 86.32 | 94.26 | 93.38 | 96.08 |
| Book Value Per Share | - | - | 3.480 | 2.060 | 1.460 | 1.220 |
| Cash Flow per Share | - | - | 1.730 | 1.140 | 0.5700 | 0.5700 |
| Capex 1 | 10.3 | 12.5 | 3.85 | 2.69 | 3.78 | 0.8 |
| Capex / Sales | 6,131.79% | 66,550.35% | 176.61% | 96.92% | 94.22% | 11.58% |
| Announcement Date | 20-04-06 | 20-04-06 | 21-04-19 | 22-05-02 | 23-04-27 | 24-04-30 |
1SEK in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +0.78% | 6.97M | |
| +18.13% | 66.57B | |
| +3.65% | 49.81B | |
| +21.27% | 42.77B | |
| +22.79% | 26.3B | |
| +10.72% | 19.26B | |
| -1.61% | 16.56B | |
| +5.48% | 15.96B | |
| -29.11% | 14.82B | |
| -11.69% | 14.45B |
- Stock Market
- Equities
- CIRCHE Stock
- Financials CirChem AB
